Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(14 sites)

France

CHU de Angers, Angers

CHU de Bordeaux, Bordeaux

Institut Bergonié, Bordeaux

CHU de Clermont-Ferrand, Clermont-Ferrand

CHD Vendée, La Roche-sur-Yon

Centre Léon Bernard, Lyon

Institut Paoli-Calmettes (Marseille), Marseille

CHU de Montpellier, Montpellier

CH Régional Universitaire de Nancy, Nancy

University Hospital, Nantes

Hôpital Avicenne (AP-HP), Paris

Hôpital Universitaire Pitié Salpêtrière de Paris, Paris

CHU de Poitiers, Poitiers

Centre Henri-Becquerel de Rouen, Rouen